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Molecular analyses of murine humoral immune responses have been largely
limited to responses induced by soluble proteins, polysaccharides, and hapten
conjugates thereof (1-15). However, in nature the mouse rarely encounters an
antigenic structure in association with such chemically simple forms, but rather
in association with a viral particle, bacterium, or parasite. How such differences
in the macromolecular form of an epitope affect the structural outcome of the
humoral immune response to that epitope is not well understood.
Antigens may differ in their humoral immunogenic properties due to differ-
ences in epitope valence, solubility, mitogenic qualities, stability, degree ofTcell
independence, adjuvant properties, and ability to be phagocytized by macro-
phages. Any one of these factors could influence the structure of antibodies
elicited to an epitope on the antigen due to resulting differences in the degree
of participation in the immune response ofTcells, accessory cells, or B cells that
are members of functionally distinct subsets or reside in particular lymphoid
microenvironments. Indeed, a number ofinvestigations (2, 16-21) have revealed
that the isotypic profile ofserum antibodies elicited to haptens can vary dramat-
ically depending on the molecular form of the haptenic determinant. Haptens
conjugated to soluble proteins often elicit antibodies mainly of the IgG1 class,
while the same haptens conjugated to polysaccharide often elicit IgM and IgG3
(2, 16, 17, 19). The immune response to viruses is nearly exclusively composed
of IgG2a (22), and the immune response to many parasites is composed predom-
inantly of IgE (23, 24). These data demonstrate that the various isotypic forms
of Ig are not selected at random for expression but that the immune system is
capable ofdistinguishing amonga variety ofmacromolecular forms ofan epitope
and regulating expression of the antibody isotypes elicited to that epitope in
response to such differences.
In contrast to the information available on the effects ofantigenic form on the
expression of Ig isotypes, little is known (2, 25, 26) about how this influences
expression of particular antibody variable region structures. While the antigenic
specificity of a V region clearly plays a role in the clonal selection process, it is
not understood whether the V region structural outcome of an antigen-driven
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immune response can be modified by processes that act independently of the
structure of the eliciting epitope. One of the factors that might well influence
such processes is the macromolecular form of the antigen . To gain insight into
this question we have conducted a molecular analysis of the humoral immune
response of A/J mice to the hapten p-azophenylarsonate (Ars)' conjugated to the
bacterial carrier Brucella abortus (Bruc) and compared the results with previous
results (1) obtained from the analysis of the A/J immune response to this same
hapten conjugated to a soluble protein carrier (Ars-keyhole limpet hemocyanin
[KLH]).
Materials and Methods
Antigen Preparations.
￿
Preparations of Bruc "tube antigen" (a heat-killed and phenol-
preserved preparation of whole bacteria) were obtained from the New Jersey division of
the U .S. Department of Agriculture. KLH was obtained from Calbiochem-Behring Corp.,
LaJolla, CA. Ars conjugates of both these antigens were prepared as previously described
(27).
Production of Hybridomas.
￿
8-wk-old female A/J mice (obtained originally from The
Jackson Laboratory, Bar Harbor, ME) were injected intraperitoneally with 100 ttl of a 1
suspension of Ars-Bruc in either CFA or PBS. Primary immune response hybridomas
were produced from the spleen cells of mice taken 4 or 5 d after this single injection.
Secondary immune response hybridomas were produced from the spleen cells of mice
taken 3 d after a secondary 100-,ul i.p. injection of a 1 % suspension of Ars-Bruc in PBS
administered 33-37 d after primary immunization as described above. Fusions were
performed using the SP2/0 parental line as previously described (28).
ScreeningofHybridoma Populations.
￿
Hybridomas expressing mRNA homologous to a
VHId"-specific DNA probe were identified using the lysate hybridization technique (28).
mAbs produced by VIdcR-expressing hybridomas were assayed for Ars-binding activity
and expression of various idiotypic determinants as described previously (29).
RNA Purification, Sequencing, and Blot Analysis.
￿
Total hybridoma RNA was purified
using the guanidine isothiocyanate lysis/CsCl gradient procedure (30, 31). Poly(A)+ RNA
was purified using oligo(dT) cellulose chromatography. The oligonucleotide-primed di-
deoxynucleotide mRNA sequencing technique was used to determine the sequences of
expressed V and V,, genes (32, 33). Oligonucleotide primers specific for the C,, GO, C7,-
Ctis:;C, 2b, and C, genes were used, as well as a primer that is specific for an internal site
in the VHId' gene segment. Northern blot analysis of total hybridoma RNA was
performed as described (34).
mAb Purification, Isotyping, and Ars Affinity Measurement.
￿
Isotypes of mAbs were de-
termined using hybridoma culture supernatants and an ELISA mouse antibody subtyping
kit (Boehringer Mannheim Diagnostics, Inc., Houston, TX). tnAbs were purified from
culture supernatants using Ars-bovine gamma globulin/Sepharose affinity chromatogra-
phy. After supernatants were loaded, the columns were washed extensively, first with
0 .05% Tween-20 in PBS and then with 3 M urea in 10 mM Tris (pH 8.0). Antibody was
eluted from the column using 2 M KSCN and the eluate was immediately dialyzed against
PBS. Ars affinities of mAbs were determined via fluorescence quenching essentially as
described previously (35). Measurements were done at 22°C using a fluorescence spectro-
photometer (model MPF-66; Perkin-Elmer Corp., Norwalk, CT). The free ligand concen-
tration at 50% of the maximum quench was used to determine association constants.
Serology.
￿
Primary Ars-Bruc immune sera were obtained on days 7, 17, and 28 after
intraperitoneal injection of five female A/J mice with 100 ltl of a 1 % suspension of Ars-
Bruc in PBS . Secondary Ars-Bruc immune sera were obtained from five female A/J mice
10 d after a secondary 100-,ul i.p. injection of 1 % Ars-Brucella (after an identical primary
' Abbreviations used in this paper:
￿
Ars, p-azophenylarsonate; Bruc, Brucella abortus "tube" antigen ;
KLH, keyhole limpet hemocyanin; TD, T cell dependent; TI, T cell independent.FISH AND MANSER
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immunization and a 38-d rest period). Secondary Ars-KLH immune sera were obtained
from 16 female A/J mice 10 d after a 100-Fg i.p. injection of Ars-KLH in PBS (after a
primary 150-wg i.p. injection of Ars-KLH emulsified in CFA and a 30-d rest period).
Quantitation of Ars-binding antibodies and idiotype in immune sera was performed as
previously described (29). Quantitative determination of the isotype distribution of Ars-
bindingantibodies in immunesera wasdetermined as follows. Serum samples werepooled
and dilutions made in 10 mg/ml BSA/0.05% Tween-20 in PBS. Ars-binding antibodies
in serum dilutions were then affinity purified by incubation on Ars-BSA-coated 96-well
polyvinyl chloride plates. After washing, appropriate dilutions (in the buffer described
above) of rabbit antisera specific for mouse IgM, IgG3, IgG1, IgG2a, or IgG2b (Litton
Bionetics, Kensington, MD) were incubated in the wells. After washing, rabbit antibody
bound to the wells was elaborated using a 121I-labeled goat anti-rabbit Ig reagent
(Southern Biotechnology Associates, Inc., Birmingham, AL) and the wells were cut and
counted using a gammacounter (model NE1600; Nuclear EnterprisesAmerica, Fairfield,
NJ). Isotype content was calculated by comparing the isotype titration curves generated
from serum samples with those generated using previously characterized Ars-binding
mAbs (all having similar affinities for Ars) of the appropriate isotypic class.
Results
We have previously reported (1) the results of a molecular analysis of the
humoral immune response of A/J mice to Ars-KLH. A major fraction of the
anti-Ars mAbs expressed by hybridomas isolated early (days 3-9) in the anti-Ars-
KLH response are encoded by a single VH gene segment (VHIdcR) in combination
with a diverse assortment of D, JH, VL, andJL gene segments. These antibodies
have low affinities for Ars on average (Ka from <5 X 10' to 5 X 105/M) and
their V regions have not been structurally altered by somatic mutation. VHIdcR-
expressing hybridomas isolated at later times (days 10-21) during the primary
Ars-KLH response (Manser, T., unpublished results) and during the secondary
response (1) are characterizedby restricted gene segmentcombinational diversity
(a V domain encoded by a single combination of gene segments termed the
"canonical" combination predominates), extensive somatic mutational alteration,
and increased (as compared with early primary antibodies) affinity for Ars (Ka
from 105 to 10'/M) . We previously suggested that an antigen-driven process of
V gene somatic mutation and clonal selection of B cells expressing high-affinity
surface Ig can best explain this maturation of the anti-Ars-KLH response (36).
We wished to determine whether altering the macromolecular form of Ars
would result in alteration of the structural maturation pathway of VHIdcR-
encoded antibodies, described above, that had been seen to occur during the
Ars-KLH response. We chose to use Bruc as an alternate Ars carrier in these
experiments for two reasons. First, Bruc is a particulate, complex bacterial
antigen that has been categorized as a T cell-independent (TI) type I antigen
(37) and hence is very different in its immunogenic properties from KLH (a T
cell-dependent (TD) soluble protein antigen). Second, serological analyses ofthe
strain A immune response to Ars-Bruc have been previously reported by Lucas
and Henry (38) and Conger et al. (39). Both groups foundthatantibodies bearing
idiotypic determinants characteristic ofantibodies encoded by the VHIdcR gene
segment (Id" determinants) were elicited to Ars conjugates of Bruc.
Hybridomas were produced from the splenic B cells of five A/J mice on days
4 and 5 of the primary Ars-Bruc response and from six mice on day 3 of the
secondary response. Since our analysis ofthe Ars-KLH response used mice that71 4
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FIGURE 1 .
￿
Nucleotide sequences of the VIdcR gene segments expressed by Ars-Bruc pri-
mary and secondary hybridomas.' The sequences are compared with the sequence of the
germline VHIdCR gene segment (VhIdCR) and another gene segment (MH Vh) thought to be
the most homologous V gene to VIdcR in the A/J genome. Sequence identity is indicated
by a dash. Nucleotide differences are shown explicitly. Nucleotide positions that could notbe
unequivocally identified are indicated by a gap. Theposition of complementarity determining
region (CDR) coding sequencesare shown above the sequences as are the positions of amino
acid codons, numbered sequentially from the mature NI-12-terminus, of theencoded polypep-
tide chain. The sequences are divided into two groups: those obtained from secondary
hybridomas, shown immediately below the germline VHIdc' sequence, and those obtained
from primary hybridomas, shown below and separated by a solid line from the secondary
sequences. The names of the hybridomas that expresseach of the V genes are indicated at
the 5' end ofeach sequence and these names are preceded by a number (1-12 for secondary
hybridomas and 13-18 for primary hybridomas) that also precedes the continuation of the
sequences for ease of alignment. Amino acid codon 58, which is often observed to have
mutated from a threonine to an isoleucine codon, is shown. Figure continued on facing page.
2 These sequence data have been submitted to the EMBL/GenBank Data Libraries under the
accession number Y00633 .10---
11---
12---
13---
14---
15---
16---
17---
18---
19---
20---
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--- --- --- -I- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
ACT GTA GAC AAA TCC TCC AGC ACA WC TAC ATG CAG CTC AGA AGC CTG ACA TCT GAG GAC TCT GCA GTC TAT TTC TGT GCA AGA
FIGURE I
￿
(continued)
had been primed with Ars-KLH in CFA, a group ofmice were primed with Ars-
Bruc in CFA to control for possible adjuvant effects. The resulting hybridomas
were screened for expression of mRNA homologousto the VHIdcR gene segment
(see Materials and Methods). Hybridomas identified in this way were then
subcloned and the sequences oftheir expressed V region genes were determined.
All of the hybridomas that were further characterized produce Ars-binding
antibodies.
Figs. 1 and 2 present the sequences of the VH genes expressed by these
hybridomas as compared with the sequence of the VH gene expressed by 36-65,
a hybridoma isolated during the A/J anti-Ars-KLH response that expresses the
canonical combination of V gene segments (VHIdcR, DGR, JH2, VKIdcR, and J,1)
in unmutated form. The primary hybridomas express the VHIdcR segment in
association with a diverse collection of D and JH segments. Most of these gene
segment combinations are similar to those previously observed (1, 13) to be
expressed by primary hybridomas isolated from the Ars-KLH response. All of
the primary Ars-Bruc hybridomas express the VHIdcR gene segment in unmu-
tated form. A single primary hybridoma (1P1C) was found to express the
canonical VH-DJH combination. Less extensiveanalysisofthe VL genes expressed
by the primary hybridomas revealed that several express VL genes related or
identical to the V. .IdcRJ.1 combination (including 1PIC), but many express
unrelated VL genes (see Table I). The observation that hybridomas expressing
the canonical combination of V gene segments can be isolated from both the
anti-Ars-KLH and anti-Ars-Bruc response strongly suggests that the antigenic
structure of Ars in the context of these two carriers is similar if not identical
(i.e., carrier components do not contribute differentially to the Ars antigenic
determinant).
The extensive combinational diversity expressed in the context of the VHIdcR
gene segment among primary hybridomas was not as apparent among the
secondary Ars-Bruc hybridomas (Fig. 2 and Table 1). Three examples of hybri-71 6
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FIGURE 2. Nucleotide sequences in the VH-DJu region of the V genes expressed by
secondaryand primary Ars-Bruc hybridomas. The sequencesare compared with thesequence
in this region of the V gene expressed by the hybridoma 36-65, a hybridomathat expresses
thecanonical combination of V gene segments in unmutated form. Sequences are aligned to
maximize homology to the36-65sequence. Sequence identity is indicatedby adash,differences
are shown explicitly. Nucleotide positions that could not be unequivocally determined are
indicated by an X. Sequences obtained from secondary Ars-Bruc hybridomas are shown
immediately belowthe 36-65sequence. Sequencesderived from primaryArs-Bruc hybridomas
are shown below the secondary sequences and are separated from these sequences by a solid
line. Two aminoacid codons that areobserved to vary amongtheVH genesexpressedby Ars-
KLH hybridomas that express the canonical combination of gene segments (amino acid
positions 100 and 107) areindicated.'
domas expressing the canonical combination of gene segments were found, and
more restricted use of D, JH, and VL segments than observed among primary
hybridomas is apparent. In addition, all of the secondary hybridomas express
somatically mutated forms of the VH1dcR gene segment (Fig. 1). Two of the
hallmarks of antigenic selection of V region somatic mutants are evident in these
gene segments; productive mutations are clustered in and around complemen-
tarity determining regions, and the same productive mutations are found at
identical positions in genes expressed by independently isolated hybridomas (e .g.,
VH position 58). Sequences of several of the VL genes expressed by VKId'-
expressing secondary hybridomas were determined and are consistent with
somatically mutated forms of the VKIdcR gene segment (reference 40; Wysocki,
L., personal communication) (see Table 1).
These data suggest that an antigen-driven process of somatic mutation and
clonal selection of B cells expressing high-affinity surface Ig entirely analogous
' Thesesequence data have been submitted to theEMBL/GenBank Data Libraries underaccession
number Y00634.
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GG G GGXCC
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TABLE I
Characteristics of mAbs Produced by Primary andSecondary Ars-Bruc Hybridoms
Mice 1-4 and 6-9 received a primary injection with Ars-Bruc in PBS. Mice 5, 10, and 11 received
Ars-Bruc in CFA. Data obtained from primaryanti-Ars-Bruc antibodies are shownin Exp. 1, those
obtained from secondary anti-Ars-Bruc antibodies are shown in Exp. 2. The presence or absence
of somatic mutations in the VIdc' gene segment encoding these antibodies was determined as
described in Materials and Methods and in the Legend to Fig. 1. Homology of the V, genes
encoding these antibodies was determined either by Northern blot analysis using a VId" probe
or by nucleotide sequencing of the V genesencoding theseproteins.
* This sequenced V,, was not homologous to the VKId " gene segment but was highly homologous
to the VK36-60 (13) gene segment.
Affinities of some of the monoclonal antibodies for Ars-tyrosine were determined as described in
Materials and Methods. The footnote indicates affinities determined for antibodies that are
encoded by the canonical combination of V region gene segments.
§ Sequenced V,; genes that appeared to be somatically mutated forms of the VKId" gene segment
in combination withJ.1 .
to the process thought to be responsible for the maturation of the Ars-KLH
response also occurs during the Ars-Bruc response. A prediction of this hypoth-
esis is that secondaryArs-Bruc hybridomas should produce mAbs that, in general,
have higher affinity for Ars than do antibodies expressed by primary Ars-Bruc
hybridomas. The Ars affinities of several of the antibodies produced by primary
and secondary Ars-Bruc hybridomas were determined and this was found to be
the case (see Table 1). In particular, the secondary hybridomas that express the
canonical combination in somatically mutated forms (ABA2'-4, ABA2'-6, and
ABA2'-7) produce antibodies that have Ars affinities 2-10-fold higher than the
antibody produced by the single primary hybridoma (1PIG) that expresses this
combination of segments in germline form.
Exp. Hybridoma Mouse
number
VIdCR
mutation
V,,
V,Idc
homolofy Isotype Affinity for Ars
M-'
1 ABA5-I 1 No No IgG2b 2.4 x 105
ABA8-1 2 No No IgG2a <8 x 104
1PIA 3 No No IgM
1PIC 3 No Yes IgG3 3.8 x 105$
1P2A 4 No No* IgM <7 x 104
1P2E 4 No No IgG2a <6 x 104
1C4A 5 No No IgM
1C4E 5 No Yes IgG2a
2 2PIA1 6 Yes Yes§ IgG2a
2PIC 6 Yes Yes IgG2a
2P2A 7 Yes No IgG2a 1.4 x 105
2P2C 7 Yes Yes§ IgG3 5.9 X 105
ABA2'-1 8 Yes No IgM
ABA2'-2 8 Yes No IgG2a
ABA2'-3 9 Yes No IgG2b
ABA2'-4 9 Yes Yes IgG2b 1.0 X 10'$
ABA2'-6 9 Yes Yes IgG2a ^-1 X 107$
ABA2'-7 9 Yes Yes IgG2b 8.8 X 106$
2C2A 10 Yes Yes§ IgG2a 5.9 X 106
2C3A 11 Yes No IgM <2 x 10471 8
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FIGURE 3 .
￿
Isotype distribution of secondary
anti-Ars serum antibodies . Mice were immu-
nized, serum samples were taken, and isotype
distribution of anti-Ars antibodies were deter-
mined as described in Materials and Methods .
The results are presented as percentage oftotal
serum anti-Ars antibody accounted for by
either IgM, IgG3, IgG I, IgG2a, or IgG2b .The
values for individual sera add up to slightly
>I00% due to mild crossreactivities of the an-
tiisotype reagents . Sera were obtained from
mice after either priming with Ars-KLH in
CFA and boosting with Ars-KLH in PBS ([I),
priming with Ars-Bruc in PBS and boosting
with Ars-Bruc in PBS (®), or priming with Ars-
Bruc in CFA and boosting with Ars-Bruc in
PBS (")
In contrast to the overall similarities of V region structure and maturation
observed between the primary and secondary groups of VHIdcR-encoded anti-
bodies elicited with Ars-KLH and Ars-Bruc, the predominant isotypic classes of
anti-Ars mAbs elicited by secondary immunization with thesetwo antigens differ .
The majority of Ars-KLH-induced secondary hybridomas produce antibodies
of the IgG 1 class (1, 41), whereas most Ars-Bruc-induced secondary hybridomas
produce either IgG2a or IgG2b (see Table 1) .
We wished to determine whether the predominant expression of IgGI among
Ars-KLH-induced secondary hybridomas, and IgG2 among Ars-Bruc-induced
secondary hybridomas was reflective of the isotypic profile of secondary anti-Ars
serum antibodies . Three groups of A/J mice were primed with either Ars-KLH
in CFA, Ars-Bruc in CFA, or Ars-Bruc in PBS . 1 mo later the Ars-KLH mice
were boosted with Ars-KLH in PBS and both groups of Ars-Bruc mice were
boosted with Ars-Bruc in PBS . 10 d later all groups of mice were bled and serum
samples from each group were pooled . The percentage of IgM and the various
IgG isotypes among the anti-Ars antibodies in each pooled serum sample was
then determined as described in Materials and Methods . The results presented
in Fig . 3 show that IgGI is the predominant isotype among secondary anti-Ars
antibodies induced with Ars-KLH, whereas IgG2a and IgG2b predominate
among secondary antibodies induced with Ars-Bruc . Fig . 3 also shows that the
relative proportion of IgG2a and IgG2b found among Ars-Bruc-induced anti-
Ars serum antibodies is influenced by whether the primary immunization was of
Ars-Bruc emulsified in CFA or Ars-Bruc in PBS .
Discussion
Our results suggest that differences in the macromolecular form of Ars have
much more dramatic effects on the isotypic profile of the anti-Ars response of
A/J mice than they do on the repertoire of V domains elicited to this haptenic
determinant . In addition, the maturation of anti-Ars V region structure previ-
ously observed to occur during the course of the anti-Ars-KLH response also
occurs in response to Ars-Bruc . The data suggest that regulation of isotype
expression during a humoral immune response need not have an effect on V
domain expression, diversification, and selection . More generally, isotype regu-FISH AND MANSER
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lation may be particularly sensitive to the macromolecular form of an epitope,
while V region regulation is particularly sensitive to its molecular structure.
Our finding that secondary anti-Ars-Bruc antibodies comprise mainly IgG2a
and IgG2b is reminiscent of the results of a previous study on the immune
response to trinitophenyl-Bruc (42). However, such an isotypic profile, and our
finding of somatic mutational diversification of V region structure during the
Ars-Bruc response, are notconsistent with many previous analyses ofTI immune
responses (2, 16-19). In fact, it has been argued that Bruc, while able to elicit
an immune response in nude mice, nevertheless bears one of the hallmarks ofa
TD antigen; it can induce a state of immunological memory in normal mice
(reference 43; Fish, S., andT. Manser, unpublished results). Theseconsiderations
point out that in the presence of a functional T cell compartment it may be an
oversimplification to consider any antigen truly T cell independent (44, 45).
Although the expression and diversification of Ars-specific V region structure
observed to occur during the Ars-KLH and Ars-Bruc responses are very similar,
several subtle differences are noteworthy. First, the absolute amount of somatic
mutational alteration of the V region genes expressed by secondary Ars-Bruc
hybridomas is somewhat less than that previously observed (1) among the V
genes expressed by secondary Ars-KLH hybridomas (1.5 vs. 3% VHIdcR nucleo-
tides mutated). In addition, the degree of predominance of expression of the
canonical combination ofgene segments among these two groups ofhybridomas
differs. 3 of 12 Ars-Bruc secondary hybridomas express this combination,
whereas our previous analysis (1) of Ars-KLH secondary hybridomas revealed
that 7 of 9 expressed this combination ofgene segments. These data suggest that
the maturation of anti-Ars V region structure may not progress to as great a
degree in response to Ars-Bruc. This may be due, in part, to the fact that the
anti-Ars response elicited by administration ofArs-Bruc in PBS (from which the
major fraction of our hybridomas was derived) results in an anti-Ars response
that is approximately fivefold lower in magnitude (as measured by levels ofserum
antibody) than the anti-Ars response elicited by Ars-KLH in CFA (data not
shown). These quantitative differences apparently cannot account for the differ-
ences in the isotypic profiles of the two anti-Ars responses, since when Ars-Bruc
is administered in CFA an anti-Ars serum antibody response results that issimilar
in magnitude to that obtained with Ars-KLH in CFA (data not shown). The
isotypic profile ofthis Ars-Bruc in CFA-primed secondary Ars-Bruc response is
characterized by the predominance of IgG2a and IgG2b (Fig. 3). In addition,
despite the differences in magnitude of the responses, similar increases in Ars
affinity between antibodies produced by primary and secondary hybridomas
isolated from the Ars-Bruc and Ars-KLH responses are observed.
Ars-KLH-induced anti-Ars antibodies encoded by VHIdcR are characterized
by the presence of a VH-D junctional serine residue (46). Replacement of this
junctional serine with alanine in a prototype canonical combination encoded V
region via site-directed mutagenesis abolishes affinity for Ars (47). This result
indicates that the reproducible occurrence of serine at the VH-D junction of
VHIdcR-encoded Ars-binding antibodies results from antigenic selection. Strik-
ingly, among 33 independently isolated anti-Ars-KLH antibodies examined to
date all VH-Djunctional serines are encoded by the TCX group ofserine codons;720
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the AGT or AGC serine codons are never observed. Many of the V regions
expressed by the Ars-Bruc-induced VHIdcR-expressing hybridomas we have
isolated also contain a TCX-encoded V,-D junctional serine. We (46) and others
(48) have argued that this biased codon usage may result from either nonrandom
de novo junctional nucleotide addition or the occasional use of an additional
TCX-containing D gene segment during the formation of VH genes that use the
VHIdcR gene segment. Apparently the TCXjunctional codon is selected at both
the protein and nucleic acid levels.
In contrast to the exclusive use of TCX to encode the VHIdcR-D junctional
serine observed among previously characterized anti-Ars-KLH antibodies (46),
two of the secondary anti-Ars-Bruc antibodies we have isolated have VHIdcR-D
junctional serine residues encoded by either AGT (2P2C) or AGC (2C2A). Both
these hybridomas express V gene segment combinations that are close approxi-
mations to the canonical combination (i.e., they express VHIdcR, DcR, VKIdcR,
andJ.I but differ in expressing JH1). Interestingly, in the D regions of the VH
genes these two hybridomas express, position 100 (the first codon 3' of the
junctional serine codon) appears to be derived from the germline DcR gene
segment (49). In the D regions of the VH genes expressed by Ars-KLH hybrido-
mas, the TCX serine codon is nearly always followed by a codon of variable
sequence, suggestive of random nucleotide addition 5' to DcR coding sequence.
Thus, the position 99 AGT and AGC codons in the VH genes expressed by the
2C2A and 2P2C hybridomas appear to have resulted from random nucleotide
addition at thejunction of the VHIdcR and Dc' segments during gene segment
joining. Why hybridomas producing Ars-binding antibodies encoded in this way
have never been isolated from the anti-Ars-KLH response is unclear. One
possibility is that Ars-Bruc can stimulate a B cell subset that does not participate
in the Ars-KLH response and differs from B cells that respond to Ars-KLH in
expression ofjunctional diversity. Indeed, it has been suggested that different
macromolecular forms of an epitope stimulate functionally distinct subpopula-
tions of both naive (50) and memory (51) B cells. Further experiments are
required to confirm these interesting but preliminary observations .
Summary
We investigated the influence of the macromolecular form of an epitope on
the structure of antibody variable and constant regions expressed by the B cell
population participating in an immune response to that epitope. Hybridomas
were constructed from strain A/J mice undergoing either primary or secondary
immune responses to p-azophenylarsonate conjugated to Brucella abortus (Ars-
Bruc). We determined the sequences of the V genes expressed by hybridomas
selected on the basis of expression of a single VH gene segment known to encode
a large family of anti-Ars antibodies. These sequences were compared with the
sequences of V genes expressed by a previously characterized panel of hybrido-
mas isolated in the same way during the primary and secondary responses of A/J
mice to Ars-KLH. The repertoire of Ars-specific V domains expressed among
primary and secondary hybridomas elicited with these two forms of Ars were
similar, as were the differencesbetween primaryand secondary V region somatic
mutational alteration and affinity for Ars. In contrast, predominant expressionof IgG2 anti-Ars antibodies was elicited in the secondary Ars-Bruc response,
whereas secondary anti-Ars antibodies elicited with Ars-KLH are predominantly
IgGI . Thus, differences in the macromolecular form of Ars clearly influence the
isotypic profile of the anti-Ars response, but the expression, diversification, and
selection of V domains elicited with this hapten are not greatly affected by such
differences. Our results suggest that while isotype regulation is highly perceptive
of the macromolecular form of a B cell epitope, V region regulation is primarily
influenced by the molecular structure of that epitope.
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